U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188731188731Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the UrotheliumCompletedNo Results AvailableBladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral CancerBiological: filgrastim|Drug: cisplatin|Drug: doxorubicin hydrochloride|Drug: gemcitabine hydrochloride|Drug: ifosfamide|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00080795
188732188732Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone MetastasesTerminatedNo Results AvailableMetastatic Cancer|Prostate CancerDrug: Celecoxib|Drug: Doxorubicin Hydrochloride|Radiation: Strontium chloride Sr 89https://ClinicalTrials.gov/show/NCT00080782
188733188733Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This DiseaseActive, not recruitingNo Results Availablebrca1 Mutation Carrier|brca2 Mutation Carrier|Breast CancerBiological: therapeutic estradiol|Drug: deslorelin|Drug: therapeutic testosterone|Procedure: therapeutic conventional surgery|Other: active surveillance|Procedure: quality-of-life assessment|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00080756
188734188734Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast CancerCompletedNo Results AvailableBreast CancerDrug: gefitinib|Drug: tamoxifen citrate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00080743
188735188735Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone MetastasesCompletedNo Results AvailableMetastatic Cancer|Prostate CancerDrug: Docetaxel|Drug: Imatinib Mesylatehttps://ClinicalTrials.gov/show/NCT00080678
188736188736Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNo Results AvailableBreast CancerDrug: docetaxel|Drug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00080665
188737188737CA-125 in Screening Patients at High Risk for Ovarian CancerWithdrawnNo Results AvailableOvarian CancerOther: physiologic testing|Procedure: study of high risk factorshttps://ClinicalTrials.gov/show/NCT00080639
188738188738Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast CancerActive, not recruitingNo Results AvailableBreast CancerBiological: pegfilgrastim|Drug: docetaxel|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00080626
188739188739Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast CancerWithdrawnNo Results AvailableStage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast CancerDrug: exemestane|Procedure: adjuvant therapy|Procedure: aromatase inhibition|Procedure: conventional surgery|Procedure: endocrine therapy|Procedure: hormone therapy|Procedure: neoadjuvant therapy|Procedure: surgeryhttps://ClinicalTrials.gov/show/NCT00080613
188740188740Brain Physiology in Polio SurvivorsCompletedNo Results AvailablePostpoliomyelitishttps://ClinicalTrials.gov/show/NCT00080600
188741188741Atherosclerosis in the Coronary and Carotid ArteriesCompletedNo Results AvailableCoronary Diseasehttps://ClinicalTrials.gov/show/NCT00080587
188742188742The Effect of Thyroid Hormone on Drug Elimination in Cancer PatientsCompletedNo Results AvailableThyroid CancerProcedure: Skin Biopsyhttps://ClinicalTrials.gov/show/NCT00080574
188743188743Timing of Voluntary Movement in Patients With SchizophreniaCompletedNo Results AvailableSchizophreniahttps://ClinicalTrials.gov/show/NCT00080548
188744188744Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell LymphomasCompletedHas ResultsLymphoma|T-Cell|CutaneousBiological: LMB-2https://ClinicalTrials.gov/show/NCT00080535
188745188745Strategies for Delivering Anti-HIV Therapy in South AfricaCompletedNo Results AvailableHIV InfectionsBehavioral: Monitoring by HIV-trained primary care nurses|Behavioral: Community-based directly observed therapy (DOT)|Drug: stavudine|Drug: lamivudine|Drug: efavirenz|Drug: zidovudine|Drug: didanosine|Drug: lopinavir/ritonavirhttps://ClinicalTrials.gov/show/NCT00080522
188746188746Effectiveness of KOS-862 in the Treatment of Lung CancerTerminatedNo Results AvailableLung CancerDrug: KOS-862https://ClinicalTrials.gov/show/NCT00080509
188747188747Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired PneumoniaCompletedNo Results AvailableBacterial PneumoniaDrug: Tigecycline|Drug: Imipenem|Drug: Cilastatinhttps://ClinicalTrials.gov/show/NCT00080496
188748188748Testosterone and Growth Hormone for Bone Loss in MenCompletedHas ResultsHypopituitarism|Hypogonadism|Growth Hormone DeficiencyDrug: Testosterone plus somatropin|Drug: testosteronehttps://ClinicalTrials.gov/show/NCT00080483
188749188749An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge IncontinenceCompletedHas ResultsUrinary IncontinenceDevice: bionhttps://ClinicalTrials.gov/show/NCT00080470
188750188750Safety and Efficacy Study of Sitaxentan Sodium (Thelinâ„¢) in Patients With Pulmonary Arterial HypertensionCompletedNo Results AvailablePulmonary HypertensionDrug: sitaxsentan sodiumhttps://ClinicalTrials.gov/show/NCT00080457
188751188751Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097)CompletedNo Results AvailableVomitingDrug: aprepitant|Drug: ondansetron|Drug: dexamethasone|Drug: placebo to aprepitant|Drug: placebo to dexamethasone|Drug: rescue medicationhttps://ClinicalTrials.gov/show/NCT00080444
188752188752Daclizumab to Treat HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Daclizumabhttps://ClinicalTrials.gov/show/NCT00080431
188753188753Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced CancerCompletedNo Results AvailableNeoplasmDrug: Liposome Entrapped Paclitaxel Easy to Usehttps://ClinicalTrials.gov/show/NCT00080418
188754188754Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple MyelomaCompletedNo Results AvailableMultiple MyelomaDrug: Bortezomibhttps://ClinicalTrials.gov/show/NCT00080405
188755188755EW-A-401 to Treat Intermittent ClaudicationCompletedNo Results AvailableIntermittent Claudication|ArteriosclerosisDrug: DNA Plasmid Vector|Drug: EW-A-401 DNA Plasmid Vectorhttps://ClinicalTrials.gov/show/NCT00080392
188756188756Octanol to Treat Essential TremorCompletedNo Results AvailableEssential TremorDrug: 1-Octanolhttps://ClinicalTrials.gov/show/NCT00080366
188757188757Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced MelanomaCompletedNo Results AvailableMelanomaDrug: IL-2|Drug: gp100:209-217|Drug: OKT3|Drug: rF-go 100P209|Drug: Montanide ISA 51https://ClinicalTrials.gov/show/NCT00080353
188758188758Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNo Results AvailableNon Small Cell Lung CarcinomaDrug: TLK286 (Telcyta) HCl for Injection|Drug: gefitinib (Iressa)https://ClinicalTrials.gov/show/NCT00080340
188759188759Study of Three Doses of Aripiprazole in Patients With Acute SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Aripiprazole|Drug: Aripiprazole|Drug: Aripiprazole|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00080327
188760188760Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression EpisodeCompletedNo Results AvailableBipolar DisorderDrug: Aripiprazole|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00080314

* Görseller ve İçerik tekif hakkına sahip olabilir